Delivery Order SPE2DE24DA017-SPE2D626F051V
- Not listed
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order from the Defense Logistics Agency's Medical Supply Chain on September 4, 2025, for the Arthrex ACP Double Syringe System. This fixed-price delivery order, valued at $3,300, is scheduled for completion by September 9, 2025, and represents a task order issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,475.00 on May 16, 2025, for the ARTHREX ACP Double Syringe System. This fixed-price contract with economic price adjustment provisions is scheduled for completion by May 21, 2025. The award carries no set-aside designation, reflecting Arthrex's strong competitive standing in the federal marketplace. The Medical Supply Chain, operating under the...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $24,750 fixed-price delivery order with economic price adjustment for the Arthrex ACP Double Syringe System on September 8, 2025, with an ultimate completion date of September 11, 2025. The award was issued by the Defense Logistics Agency's Medical Supply Chain without a set-aside designation, reflecting Arthrex's competitive strength in the federal marketplace. The product will be...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $2,475 fixed-price delivery order on August 8, 2025, for the Arthrex ACP Double Syringe System. The contract, issued by the Defense Logistics Agency's Medical Supply Chain, carries an ultimate completion date of August 13, 2025, and represents a non-set-aside award. This delivery order falls under the company's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $8,250 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, for the Arthrex ACP Double Syringe System. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 7, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $4,950 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on September 18, 2025, for the Arthrex ACP Double Syringe System. This delivery order, with an ultimate completion date of September 23, 2025, was awarded without a set-aside designation, reflecting Arthrex's strong competitive standing in the federal orthopedic medical device marketplace. The...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $8,250.00 for the Arthrex ACP Double Syringe System on September 15, 2025. This fixed-price delivery order with economic price adjustment is scheduled for ultimate completion on September 18, 2025, and will be performed at the company's Naples, FL facility. The award was issued by the Defense Logistics Agency's Medical Supply Chain, a...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $5,775 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on July 23, 2025, for the Arthrex ACP Double Syringe System. This delivery order, with an ultimate completion date of July 28, 2025, represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million...
- Arthrex Inc., a leading developer and supplier of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, received a delivery order valued at $2,475 for the Arthrex ACP Double Syringe System from the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment capability was awarded on August 18, 2025, with an ultimate completion date of August 21, 2025. The contract represents no set-aside designation,...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a $4,950 delivery order from the Defense Logistics Agency's Medical Supply Chain on September 16, 2025, for the Arthrex ACP Double Syringe System. This fixed-price contract with economic price adjustment authority represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) valued at $471 million and running through September 1, 2029. The contract was awarded without set-aside...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D626F051VDelivery Order
Arthrex Inc., a leading manufacturer of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, received a delivery order valued at $4,950 for the Arthrex ACP Double Syringe System from the Defense Logistics Agency's Medical Supply Chain on November 7, 2025. The contract utilizes fixed-price pricing with economic price adjustment and carries an ultimate completion date of November 13, 2025. This award was issued without a set-aside designation, reflecting Arthrex's competitive position as a sole prime contractor with no identified subcontractors. The work will be performed in Naples, Florida. This delivery order is issued under Arthrex's existing single-award Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain, valued at $471.0 billion and effective through September 1, 2029. The master contract enables rapid procurement of orthopedic products and surgical technologies to support Department of Veterans Affairs medical centers and Department of Defense healthcare facilities nationwide. The ACP Double Syringe System delivery aligns with Arthrex's broad portfolio of orthopedic implants, arthroscopic instruments, biologics, and specialized surgical solutions that support comprehensive orthopedic care for military personnel and veterans across multiple surgical specialties.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 11/7/25 |